Dollvet

From its establishment in 2002 to the present, Dollvet has sensitively focused on importance of technical infrastructure, equipment, large staff and human resources. As of 2019, more than half of over 150 employees consists of experts that highly qualified technical staff. With its contemporary infrastructure, extensive expert staff and experience, Dollvet produces ultimate vaccines at domestic and international level against outbreak disease that endangers livestock economies of countries. Biotechnological product investments have a strategic importance for all of independent world countries. These product investments have a strategical importance for all of independent world countries. These products play an important role in services of fighting against outbreak diseases that affect national economies deeply and constitute extreme dangers for human and animal health.